DeepMed Research

Chinese Academy of Medical Sciences Peking Union Medical College Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.

Phase 2

Not yet recruiting

Conditions: EGFR Exon 21 Mutation
Non Small Cell Lung Cancer
Immune Checkpoint Inhibitor

Interventions: Drug: Pembrolizumab, pemetrexed, platinum
Drug: Osimertinib

First Posted Date: 2023-11-21

Last Posted Date: 2023-11-21

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 37

Registration Number: NCT06142617

Locations: 🇨🇳
Peking Union Medical College Hospital, Peking, China

[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease

Recruiting

Conditions: Alzheimer's Disease

Interventions: Drug: [18F]Florbetazine ([18F]92)
Drug: [11C]PIB

First Posted Date: 2023-11-21

Last Posted Date: 2023-11-21

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 150

Registration Number: NCT06141356

Locations: 🇨🇳
Department of Nuclear Medicine, Peking Union Medical College Hopital, Beijing, China

the Effects of Different Therapy Regimens on Menopausal Sleep Disorders

Phase 4

Not yet recruiting

Conditions: Menopause
Sleep Disorder

Interventions: Drug: Xiangshao granules
Drug: Tibolone plus Xiangshao granules
Drug: Tibolone

First Posted Date: 2023-11-07

Last Posted Date: 2024-01-02

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 180

Registration Number: NCT06117969

99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Diagnostic Test: 99mTc-MY6349 SPECT/CT scan

First Posted Date: 2023-10-27

Last Posted Date: 2023-10-27

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 30

Registration Number: NCT06104085

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC

Completed

Conditions: Breast Cancer

Interventions: Procedure: Breast Conserving Surgery
Procedure: Mastectomy

First Posted Date: 2023-10-26

Last Posted Date: 2023-10-26

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 1020

Registration Number: NCT06103032

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Learning Curve of Robotic Pancreatoduodenectomy

Completed

Conditions: Pancreaticoduodenectomy

Interventions: Other: Different phase of the learning curve of RPD

First Posted Date: 2023-10-23

Last Posted Date: 2023-10-23

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 100

Registration Number: NCT06094465

Locations: 🇨🇳
Department of General Surgery, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, Beijing, Beijing, China

Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient

Recruiting

Conditions: Pancreatic Cancer

Interventions: Other: Observational study

First Posted Date: 2023-10-19

Last Posted Date: 2023-10-19

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 450

Registration Number: NCT06090825

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Characteristics of Renal Blood Flow in AKI Patients in ICU and Its Clinical Significance

Completed

Conditions: Renal Artery Blood Flow
Renal Venous Return
Acute Kidney Injury
Renal Microcirculation

First Posted Date: 2023-10-19

Last Posted Date: 2024-02-09

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 96

Registration Number: NCT06090773

Locations: 🇨🇳
Rongping Chen, Beijing, Beijing, China

Initial Volume Status in Patients With Acute Brain Injury is Associated With Neurological Prognosis

Completed

Conditions: Acute Brain Injury
Volume Status
Paroxysmal Sympathetic Hyperactivity
Right Heart Function
Right Cardiogenic Pulmonary Edema
Glasgow Outcome Scale Extended

Interventions: Other: Ultrasound evaluation

First Posted Date: 2023-10-19

Last Posted Date: 2024-04-01

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 30

Registration Number: NCT06090812

Locations: 🇨🇳
Wei Du, Beijing, Beijing, China

Application of 68Ga-Pentixafor PET/CT for Thymoma

Early Phase 1

Recruiting

Conditions: Thymoma

Interventions: Drug: 68Ga-Pentixafor

First Posted Date: 2023-10-17

Last Posted Date: 2023-10-17

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 100

Registration Number: NCT06086327

Locations: 🇨🇳
Peking Union Medical College Hospitall, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy